Kwok
Kwok Fai Chan, Burnaby CA
Patent application number | Description | Published |
---|---|---|
20130103770 | DISTRIBUTED SEMI-SYNCHRONIZED EVENT DRIVEN PLAYBACK OF MULTIMEDIA - A system is provided for enabling attendees of an online broadcast within a collaborative environment to interact with multimedia content during the online broadcast. By rendering the content itself instead of images derived from the content that cannot be interacted with, attendees are enabled to either drive their own multimedia experience, including play, seek, pause/stop, or follow the presenter and consume the multimedia based on the presenter's action (play, pause, stop, seek). The multimedia content may be rendered on each attendee's individual client device through local caching, which contributes to playback quality such that each individual attendee may be able to interact with and control the playback experience of the multimedia content independently. | 04-25-2013 |
Kwok Ng, Milpitas, CA US
Patent application number | Description | Published |
---|---|---|
20140307947 | Design Based Sampling and Binning for Yield Critical Defects - Methods and systems for design based sampling and binning for yield critical defects are provided. One method includes aligning each image patch in each inspection image frame generated for a wafer by an optical subsystem of an inspection system to design information for the wafer. The method also includes deriving multiple layer design attributes at locations of defects detected in the image patches. In addition, the method includes building a decision tree with the multiple layer design attributes. The decision tree is used to separate the defects into bins with different yield impacts on a device being formed on the wafer. The method also includes binning the defects with the decision tree. | 10-16-2014 |
Kwok Wong, Chapell Hill, NC US
Patent application number | Description | Published |
---|---|---|
20120100100 | CYCLIN DEPENDENT KINASE INHIBITORS AND METHODS OF USE - The presently disclosed subject matter relates to methods and compositions for protecting healthy cells from damage due to DNA damaging agents. In particular, the presently disclosed subject matter relates to the protective action of selective cyclin dependent kinase 4/6 (CDK4/6) inhibitors administered to subjects that have been exposed to or that are at risk of exposure to DNA damage. | 04-26-2012 |